Parexel Master Logo_CMYK.png
Parexel Expands Global Regulatory Capabilities with Experts from FDA, EMA, NMPA and Spanish AEMPS
July 23, 2020 09:00 ET | Parexel International LLC
BOSTON and DURHAM, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel Master Logo_CMYK.png
Parexel and TriNetX Partner to Advance Real-world Data Use in Clinical Development
June 18, 2020 08:00 ET | Parexel International LLC
BOSTON and DURHAM, N.C., and CAMBRIDGE, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Parexel and TriNetX today announced a strategic effort through which they will securely connect healthcare data to...
Parexel Master Logo_CMYK.png
Parexel Adds APANDEMIC and Datavant to Lead Ongoing Advancement of #KeepingPatientsFirst Platform
June 16, 2020 09:00 ET | Parexel International LLC
BOSTON and DURHAM, N.C., June 16, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel Master Logo_CMYK.png
Parexel and Society for Clinical Research Sites Host Joint Summit of Site and Patient Advisory Councils Focused on Optimizing Site and Patient Relationships in Clinical Trials
May 20, 2020 15:41 ET | Parexel International LLC
BOSTON and DURHAM, N.C., May 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel Master Logo_CMYK.png
Parexel Launches New #KeepingPatientsFirst Integrated Research Platform Powered by Microsoft Azure Providing Rapid Access to Critical New COVID-19 Data
May 20, 2020 09:00 ET | Parexel International LLC
BOSTON and DURHAM, N.C., May 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel Master Logo_CMYK.png
Parexel Joins Forces with ACRO to Help Administer and Oversee COVID-19 Testing in UK
May 14, 2020 14:20 ET | Parexel International LLC
BOSTON, and DURHAM, N.C., May 14, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel Master Logo_CMYK.png
Parexel Supports Life Sciences Manufacturers in Safely Ensuring Business Continuity With COVID-19 Risk Mitigation Offering
May 11, 2020 09:30 ET | Parexel International LLC
Company to leverage global pandemic expertise along with cGMP inspection and CMC review experience from former global health authority leaders to help companies ensure an uninterrupted supply of...
Parexel Master Logo_CMYK.png
Parexel Recognized for High-Quality Service in CRO and Investigative Site Survey Benchmark Reports
April 16, 2020 09:00 ET | Parexel International LLC
BOSTON and DURHAM, N.C., April 16, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel Master Logo_CMYK.png
Parexel Announces Acquisition of Leading Pharmacology Modeling & Analytics Modeling Firm Model Answers
February 20, 2020 10:00 ET | Parexel International LLC
BOSTON and DURHAM, N.C. and BRISBANE, Australia , Feb. 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to...
Parexel Master Logo_CMYK.png
RenovoRx and Parexel Biotech Reach Key Milestone in Clinical Trial for Locally-Advanced Pancreatic Cancer
January 13, 2020 09:00 ET | Parexel International LLC
LOS ALTOS, Calif. and BOSTON and DURHAM, N.C., Jan. 13, 2020 (GLOBE NEWSWIRE) -- RenovoRx, Inc., an innovator in targeted cancer therapy, and Parexel Biotech, a division of Parexel, one of the...